Clinical Trials Directory

Trials / Completed

CompletedNCT01723267

Automated 3D (SonoAVC) Versus 2D Ovarian Follicles Assessment in IVF Cycles: a Randomized Controlled Trial

Automated 3D (SonoAVC) vs 2D Ovarian Follicles Assessment in IVF Cycles: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Rabin Medical Center · Academic / Other
Sex
Female
Age
18 Years – 39 Years
Healthy volunteers
Not accepted

Summary

Accurate assessment of the size of follicles is important in IVF treatment.Timing of oocyte maturation and subsequent egg collection is largely based on follicle size. An accurate assessment of follicle size and appropriate timing of HCG result in retrieval of more mature oocytes, improved fertilization and higher pregnancy rates. in 3D technology- fter the capturing of a 3D image of an ovary, SonoAVC automatically analyzes the volume dataset, identifies the boundaries of hypoechoic follicles, and provides estimates of their absolute dimensions. These measurements include the largest diameters in three orthogonal planes, the mean follicular diameter (MFD), the volume of the follicle, and the volume-based diameter (d(V)) of the follicle. In the current study the investigators aim to evaluate the use of this automated technique of follicle measurement vs. standard 2D technology on the timing of oocyte maturation and subsequent oocyte retrieval. The investigators speculate that 3D assessment will increase the rate of mature oocyte collection, and eventually will improve other treatment outcomes such as fertilization rate.

Detailed description

Not desired

Conditions

Interventions

TypeNameDescription
OTHER3D follicles assessment3D ultrasound evaluation in IVF treatment (vs 2D ultrasound)
OTHER2D follicles assessment2D ultrasound in IVF treatment (vs 3D ultrasound)

Timeline

Start date
2012-12-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-11-07
Last updated
2016-04-12

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01723267. Inclusion in this directory is not an endorsement.